DNA methylation-based molecular prognostic test for early-stage melanoma.
| Date | Round | Amount |
|---|---|---|
| Dec 2023 | Funding round Dutch MLA Diagnostics secured an undisclosed strategic seven-figure investment from NLC Health Ventures, LIOF and Brightlands Life Sciences Ventures for melanoma diagnostics clinical trials. | — |